Who invested in Cantargia?
One investor is on record as having backed Cantargia — Developing antibody drugs targeting IL1RAP, in Biotech, Sweden. Each row below says whether the round came from the investor's own portfolio page or from the press.
cantargia.comCantargia investors
No round dates are on record for Cantargia. A portfolio page names its companies far more often than it dates the cheque, and we would rather leave the field empty than guess it.
The funds that backed Cantargia are in the directory.
If they wrote this cheque, they may write yours. Pitch2Fund scores your startup against every one of them, gives you the partner to write to, and drafts the email. Free.